Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

45
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
45
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

55
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
55
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

53
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
53
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

14
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
14
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

27
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
27
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

20
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
20

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin deficient mice.

EMBO molecular medicine·2026
Same author

Withdrawal Note: Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice.

EMBO molecular medicine·2026
Same author

Organoid models through the lens of metabolomics: a systematic review of experimental applications and analytical approaches.

The Analyst·2026
Same author

Micro- and Nanoplastics as Disruptors of Digestive and Hepatopancreatic Homeostasis: Insights into the Plastic-Gut-Liver Axis.

International journal of molecular sciences·2026
Same author

A longitudinal comparative analysis of serum metabolomic signatures in children with SARS-CoV-2 infection and MIS-C.

Communications medicine·2026
Same author

No Difference in Pain Levels and Functional Outcomes After Primary Hip Arthroscopy With Labral Repair Versus Labral Augmentation at Minimum 1-Year Follow-Up.

Arthroscopy, sports medicine, and rehabilitation·2025

Related Experiment Video

Updated: May 10, 2025

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.2K

Double-Weighted Bayesian Model Combination for Metabolomics Data Description and Prediction.

Jacopo Troisi1,2,3, Martina Lombardi1,2, Alessio Trotta1,2

  • 1Theoreo srl, Via degli Ulivi 3, 84090 Montecorvino Pugliano, SA, Italy.

Metabolites
|April 25, 2025
PubMed
Summary

A new double-weighted Bayesian Ensemble Machine Learning (DW-EML) model enhances metabolomics data analysis. This AI tool offers improved accuracy and reliability for disease diagnosis and precision medicine applications.

Keywords:
Bayesian modeldiagnostic toolsensemble machine learningmetabolomicsprecision medicine

More Related Videos

A Strategy for Sensitive, Large Scale Quantitative Metabolomics
14:18

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

20.9K
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

406

Related Experiment Videos

Last Updated: May 10, 2025

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.2K
A Strategy for Sensitive, Large Scale Quantitative Metabolomics
14:18

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

20.9K
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

406

Area of Science:

  • Computational Biology
  • Bioinformatics
  • Machine Learning

Background:

  • Metabolomics offers insights into biological processes and disease states.
  • Growing role of metabolomics in disease diagnosis and precision medicine.
  • Need for robust AI tools in medical applications of metabolomics.

Purpose of the Study:

  • Introduce a novel double-weighted Bayesian Ensemble Machine Learning (DW-EML) model.
  • Improve classification and prediction accuracy for metabolomics data.
  • Enhance reliability and accuracy in medical applications.

Main Methods:

  • Developed a DW-EML model integrating multiple classifiers.
  • Employed a double-weighted voting scheme based on cross-validation accuracy and classification confidence.
  • Applied the model to publicly available metabolomics datasets.

Main Results:

  • The DW-EML model demonstrated superior performance compared to traditional methods.
  • Outperformed Partial Least Squares Discriminant Analysis (PLSDA) in accuracy and predictive power.
  • Validated on diverse datasets including critical illness, typhoid carriage, and ovarian cancer detection.

Conclusions:

  • DW-EML is a robust and reliable tool for metabolomic data analysis.
  • Offers potential for improved diagnostic and prognostic applications.
  • Contributes to the advancement of personalized and precision medicine.